{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:24:39Z","timestamp":1789050279228,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala"},{"name":"Department of Biotechnology, New Delhi, India","award":["BT\/PR4548\/INF\/22\/146\/2012"],"award-info":[{"award-number":["BT\/PR4548\/INF\/22\/146\/2012"]}]},{"name":"Indian Council of Medical research, Ansari Nagar, New Delhi, India","award":["BIC\/11(02)\/2015"],"award-info":[{"award-number":["BIC\/11(02)\/2015"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.ejphar.2016.05.019","type":"journal-article","created":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T06:53:33Z","timestamp":1463208813000},"page":"111-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Adjuvant indoleamine 2,3-dioxygenase enzyme inhibition for comprehensive management of epilepsy and comorbid depression"],"prefix":"10.1016","volume":"784","author":[{"given":"Tanveer","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh Kumar","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2016.05.019_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.tox.2007.11.003","article-title":"Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity","volume":"244","author":"Ahuja","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.ejphar.2016.05.019_bib2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-4886(86)90111-1","article-title":"Kindling antagonism: effects of norepinephrine depletion on kindled seizure suppression after concurrent, alternate stimulation in rats","volume":"94","author":"Applegate","year":"1986","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2016.05.019_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4137\/IJTR.S6225","article-title":"Rapid isocratic liquid chromatographic separation and quantification of tryptophan and six kynurenine metabolites in biological samples with ultraviolet and fluorimetric detection","volume":"3","author":"Badawy","year":"2010","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.ejphar.2016.05.019_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0197-0186(94)90130-9","article-title":"Sodium valproate induced alterations in monoamine levels in different regions of the rat brain","volume":"24","author":"Baf","year":"1994","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2016.05.019_bib5","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1111\/j.1528-1167.2008.01642.x","article-title":"Glutamine synthetase becomes nitrated and its activity is reduced during repetitive seizure activity in the pentylentetrazole model of epilepsy","volume":"49","author":"Bidmon","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2016.05.019_bib6","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1471-4159.1992.tb11001.x","article-title":"Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine, and their metabolites in the rat brain: an in vivo microdialysis study","volume":"59","author":"Biggs","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2016.05.019_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.eplepsyres.2011.05.023","article-title":"Triheptanoin -- a medium chain triglyceride with odd chain fatty acids: a new anaplerotic anticonvulsant treatment?","volume":"100","author":"Borges","year":"2012","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2016.05.019_bib8","first-page":"12","article-title":"Kynurenines in CNS disease: regulation by inflammatory cytokines","volume":"8","author":"Campbell","year":"2015","journal-title":"Brain-immune Interact. Health Dis."},{"key":"10.1016\/j.ejphar.2016.05.019_bib9","first-page":"3638","article-title":"The mouse forced swim test","volume":"59","author":"Can","year":"2012","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ejphar.2016.05.019_bib10","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/bph.12052","article-title":"Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?","volume":"168","author":"Cardamone","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.05.019_bib11","doi-asserted-by":"crossref","first-page":"479364","DOI":"10.1155\/2010\/479364","article-title":"Molecular and therapeutic potential and toxicity of valproic acid","volume":"2010","author":"Chateauvieux","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.ejphar.2016.05.019_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2013.02.012","article-title":"Ameliorative effect of Curcumin on seizure severity, depression like behavior, learning and memory deficit in post-pentylenetetrazole-kindled mice","volume":"704","author":"Choudhary","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.05.019_bib13","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1471-4159.1994.62031137.x","article-title":"Valproate increases glutaminase and decreases glutamine synthetase activities in primary cultures of rat brain astrocytes","volume":"62","author":"Collins","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2016.05.019_bib14","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/0028-3908(88)90072-X","article-title":"Characteristics of accelerated kindling after depletion of noradrenaline in adult rats","volume":"27","author":"Corcoran","year":"1988","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2016.05.019_bib15","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-015-9617-0","article-title":"Indoleamine-2,3-dioxygenase\/kynurenine pathway as a potential pharmacological target to treat depression associated with diabetes","author":"da Silva Dias","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2016.05.019_bib16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2013.06.043","article-title":"Pentylentetrazole-induced loss of blood-brain barrier integrity involves excess nitric oxide generation by neuronal nitric oxide synthase","volume":"1530","author":"Danjo","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2016.05.019_bib17","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.yebeh.2005.06.003","article-title":"New facets of the neuropathology and molecular profile of human temporal lobe epilepsy","volume":"7","author":"de Lanerolle","year":"2005","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ejphar.2016.05.019_bib18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0140-6736(03)15166-5","article-title":"Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsy","volume":"363","author":"Eid","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2016.05.019_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbi.2015.12.020","article-title":"Mouse chronic social stress increases blood and brain kynurenine pathway activity and fear behaviour: Both effects are reversed by inhibition of indoleamine 2,3-dioxygenase","volume":"54","author":"Fuertig","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejphar.2016.05.019_bib20","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.pnpbp.2007.08.031","article-title":"Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline","volume":"32","author":"Fujita","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2016.05.019_bib21","first-page":"809843","article-title":"Depression in temporal lobe epilepsy: a review of prevalence, clinical features, and management considerations","volume":"2012","author":"Garcia","year":"2012","journal-title":"Epilepsy Res. Treat."},{"key":"10.1016\/j.ejphar.2016.05.019_bib22","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jep.2015.09.025","article-title":"Pharmacological validation of in-silico guided novel nootropic potential of Achyranthes aspera L","volume":"175","author":"Gawande","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2016.05.019_bib23","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1212\/01.wnl.0000252813.86812.81","article-title":"Hippocampal 1H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy","volume":"68","author":"Gilliam","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2016.05.019_bib24","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1210\/endo-74-4-653","article-title":"Fluorometric determination of corticosterone and cortisol in 0.02\u20130.05 milliliters of plasma or submilligram samples of adrenal tissue","volume":"74","author":"Glick","year":"1964","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2016.05.019_bib25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0166-2236(96)10069-2","article-title":"Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis","volume":"20","author":"Herman","year":"1997","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2016.05.019_bib26","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.neuroscience.2008.12.040","article-title":"Paradoxical facilitation of pentylenetetrazole-induced convulsion susceptibility in mice lacking neuronal nitric oxide synthase","volume":"159","author":"Itoh","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2016.05.019_bib27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1615\/CritRevNeurobiol.v13.i4.10","article-title":"A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders","volume":"13","author":"Jobe","year":"1999","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.ejphar.2016.05.019_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.yebeh.2003.10.004","article-title":"Depression in epilepsy: a frequently neglected multifaceted disorder","volume":"4","author":"Kanner","year":"2003","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ejphar.2016.05.019_bib29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.expneurol.2014.09.004","article-title":"Sucrose consumption test reveals pharmacoresistant depression-associated behavior in two mouse models of temporal lobe epilepsy","volume":"263","author":"Klein","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2016.05.019_bib30","article-title":"Inflammation in depression and the potential for anti-inflammatory treatment","author":"K\u00f6hler","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2016.05.019_bib31","first-page":"H457","article-title":"Sympatho-adrenal responses of spontaneously hypertensive rats to immobilization stress","volume":"236","author":"Kvetnansky","year":"1979","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2016.05.019_bib32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/jnnp.43.1.68","article-title":"Platelet monoamine oxidase activity in epilepsy","volume":"43","author":"Kruk","year":"1980","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ejphar.2016.05.019_bib33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0920-1211(94)00069-9","article-title":"Platelet and brain GABA-transaminase and monoamine oxidase activities in patients with complex partial seizures","volume":"20","author":"Kumlien","year":"1995","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2016.05.019_bib34","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.eplepsyres.2011.02.003","article-title":"Increased indoleamine 2,3-dioxygenase (IDO) activity in idiopathic generalized epilepsy","volume":"94","author":"Liimatainen","year":"2011","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2016.05.019_bib35","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrd4126","article-title":"New avenues for anti-epileptic drug discovery and development","volume":"12","author":"L\u00f6scher","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2016.05.019_bib36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(84)90509-9","article-title":"Valproic acid increases gamma-aminobutyric acid in CSF of epileptic children","volume":"2","author":"L\u00f6scher","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2016.05.019_bib37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neuroscience.2012.12.052","article-title":"The kynurenine pathway: a missing piece in the puzzle of valproate action?","volume":"234","author":"Maciejak","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2016.05.019_bib38","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12640-013-9441-0","article-title":"Valproate disturbs the balance between branched and aromatic amino acids in rats","volume":"25","author":"Maciejak","year":"2014","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2016.05.019_bib39","first-page":"CD010682","article-title":"Antidepressants for people with epilepsy and depression","volume":"12","author":"Maguire","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2016.05.019_bib40","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.nbd.2009.02.018","article-title":"Elevated plasma corticosterone level and depressive behavior in experimental temporal lobe epilepsy","volume":"34","author":"Mazarati","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2016.05.019_bib41","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/brain\/awn117","article-title":"Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine","volume":"131","author":"Mazarati","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2016.05.019_bib42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/phar.1549","article-title":"Breakthrough seizures after starting vilazodone for depression","volume":"35","author":"McKean","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejphar.2016.05.019_bib43","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejphar.2011.11.010","article-title":"Age dependent learning and memory deficit in Pentylenetetrazol kindled mice","volume":"674","author":"Mishra","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.05.019_bib44","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1007\/s11064-013-1163-4","article-title":"Psychoneurochemical investigations to reveal neurobiology of memory deficit in epilepsy","volume":"38","author":"Mishra","year":"2013","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2016.05.019_bib45","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/bcpt.12275","article-title":"Adjuvant anticholinesterase therapy for the management of epilepsy-induced memory deficit: a critical pre-clinical study","volume":"115","author":"Mishra","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2016.05.019_bib46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1742-2094-10-43","article-title":"Neuroinflammation and psychiatric illness","volume":"10","author":"Najjar","year":"2013","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.ejphar.2016.05.019_bib47","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.10360","article-title":"Neuronal and glial metabolite content of the epileptogenic human hippocampus","volume":"52","author":"Petroff","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejphar.2016.05.019_bib48","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1528-1167.2010.02623.x","article-title":"Comorbidity between epilepsy and depression: experimental evidence for the involvement of serotonergic, glucocorticoid, and neuroinflammatory mechanisms","volume":"51","author":"Pineda","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2016.05.019_bib49","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.autrev.2014.09.001","article-title":"The importance of cytokines and autoantibodies in depression","volume":"14","author":"Postal","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ejphar.2016.05.019_bib50","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.yebeh.2012.11.004","article-title":"Effect of saponin fraction from Ficus religiosa on memory deficit, and behavioral and biochemical impairments in pentylenetetrazol kindled mice","volume":"27","author":"Singh","year":"2013","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ejphar.2016.05.019_bib51","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.yebeh.2014.10.002","article-title":"Ficus religiosa L. figs \u2013 a potential herbal adjuvant to phenytoin for improved management of epilepsy and associated behavioral comorbidities","volume":"41","author":"Singh","year":"2014","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ejphar.2016.05.019_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuro.2015.04.007","article-title":"Neuroprotective effect of Allium cepa L. in aluminium chloride induced neurotoxicity","volume":"49","author":"Singh","year":"2015","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ejphar.2016.05.019_bib53","doi-asserted-by":"crossref","unstructured":"Sharma M., Anand C., Chugani D.C., 2015. Role of the kynurenine pathway in epilepsy. In: Targeting the Broadly Pathogenic Kynurenine Pathway, Mittal S., (Ed), Springer International Publishing, Switzerland, pp. 205\u2013213.","DOI":"10.1007\/978-3-319-11870-3_16"},{"key":"10.1016\/j.ejphar.2016.05.019_bib54","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/jcbfm.2013.54","article-title":"Brain mitochondrial metabolic dysfunction and glutamate level reduction in the pilocarpine model of temporal lobe epilepsy in mice","volume":"33","author":"Smeland","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejphar.2016.05.019_bib55","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.neuropharm.2008.02.006","article-title":"Direct enhancement of hippocampal dopamine or serotonin levels as a pharmacodynamic measure of combined antidepressant-anticonvulsant action","volume":"54","author":"Smolders","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2016.05.019_bib56","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2016.05.019_bib57","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00702-011-0700-z","article-title":"The effects of electrical hippocampal kindling of seizures on amino acids and kynurenic acid concentrations in brain structures","volume":"119","author":"Szyndler","year":"2012","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejphar.2016.05.019_bib58","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1212\/01.WNL.0000149636.44660.99","article-title":"Reduced glutamine synthetase in hippocampal areas with neuron loss in temporal lobe epilepsy","volume":"64","author":"van der Hel","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2016.05.019_bib59","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1124\/pr.113.008144","article-title":"Neuroinflammation and comorbidity of pain and depression","volume":"66","author":"Walker","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2016.05.019_bib60","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.neuroscience.2014.12.021","article-title":"Minocycline inhibits brain inflammation and attenuates spontaneous recurrent seizures following pilocarpine-induced status epilepticus","volume":"287","author":"Wang","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2016.05.019_bib61","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/j.neubiorev.2012.12.007","article-title":"The neurobiology of depression and antidepressant action","volume":"37","author":"Willner","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2016.05.019_bib62","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/ph3010273","article-title":"Nitric oxide synthase inhibitors as antidepressants","volume":"3","author":"Wegener","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejphar.2016.05.019_bib63","series-title":"Clinical, Research and Treatment Approaches to Affective Disorders","first-page":"235","article-title":"Depression viewed as a GABA\/Glutamate imbalance in the central nervous system","author":"Wiero\u0144ska","year":"2012"},{"issue":"11","key":"10.1016\/j.ejphar.2016.05.019_bib64","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1742-2094-11-41","article-title":"Activation of brain indoleamine 2,3-dioxygenase contributes to epilepsy-associated depressive-like behavior in rats with chronic temporal lobe epilepsy","volume":"4","author":"Xie","year":"2014","journal-title":"J. Neuroinflammation."},{"key":"10.1016\/j.ejphar.2016.05.019_bib65","doi-asserted-by":"crossref","unstructured":"Zapata, A., Chefer, V.I., Shippenberg, T.S., Denoroy, L., 2009. Detection and quantification of neurotransmitters in dialysates, in: Crawley, J. N. et al., (Eds.), Current Protocol in Neuroscience. Chapter 7, Unit 7.4. pp. 1\u201330.","DOI":"10.1002\/0471142301.ns0704s48"},{"key":"10.1016\/j.ejphar.2016.05.019_bib66","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.pnpbp.2006.05.015","article-title":"Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine","volume":"30","author":"Zhang","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916303247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916303247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T01:27:46Z","timestamp":1536715666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299916303247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":66,"alternative-id":["S0014299916303247"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.05.019","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant indoleamine 2,3-dioxygenase enzyme inhibition for comprehensive management of epilepsy and comorbid depression","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}